trending Market Intelligence /marketintelligence/en/news-insights/trending/_wSm-lERvdA5V9QYD02IXQ2 content esgSubNav
In This List

CVS Health posts Q4 profit

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Earnings forecasts for US banks; corporate deleveraging; LatAm currency gains

Blog

Insight Weekly: M&A slows down; climate tops proxy season; private equity pours into blockchain


CVS Health posts Q4 profit

CVS Health Corp. said its fourth-quarter normalized net income came to $1.67 billion.

Normalized net income excludes unusual gains or losses on a pre- and after-tax basis.

The normalized profit margin was 4.1%.

Total revenue came to $41.15 billion, and total operating expenses came to $38.25 billion.

Reported net income came to $1.50 billion, or $1.34 per share.

For the year, the company's normalized net income totaled $4.98 per share, compared with the S&P Capital IQ consensus normalized EPS estimate of $5.17.

EPS rose 13.6% from $4.38 in the prior year.

Normalized net income was $5.61 billion, an increase of 9.5% from $5.12 billion in the prior year.

Full-year total revenue grew 10.0% on an annual basis to $153.29 billion from $139.37 billion, and total operating expenses rose 9.9% year over year to $143.53 billion from $130.54 billion.

The company said reported net income increased 12.4% year over year to $5.20 billion, or $4.62 per share, in the full year, from $4.63 billion, or $3.96 per share.